SALEM INVESTMENT COUNSELORS INC
Position in HIMS — Hims & Hers Health, Inc.
CIK 884423
WINSTON-SALEM, NC
Position in HIMS
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$21,279
-$8,668,764 QoQ
Shares Held
1,025
-99.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 39.02439024390244.ToString("F0")%
Shared 0.ToString("F0")%
None 60.97560975609756.ToString("F0")%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SALEM INVESTMENT COUNSELORS INC holds $527,346 across 13 Drug Manufacturers - Specialty & Generic names. HIMS ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
16,696 | $225,562 | |
| 2 | HLN |
Haleon plc
|
9,114 | $91,231 | |
| 3 | ZTS |
Zoetis Inc.
|
586 | $69,271 | |
| 4 | DERM |
Journey Medical Corp
|
14,300 | $67,067 | |
| 5 | HROW |
Harrow, Inc.
|
1,300 | $45,838 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
This page
|
1,025 | $21,279 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
331 | $2,141 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
200 | $1,904 |
All Filings in HIMS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,279 | 1,025 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $8,690,043 | 267,633 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $14,905,051 | 262,783 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $13,068,825 | 262,163 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $7,844,579 | 265,468 | Shares | Sole | 2025-04-16 | |
| No filing history on record for this holder in this stock. | ||||||